Naturally Splendid’s (TSXV:NSP) recently acquired packaging system has been successfully installed and has commenced operations. Naturally Splendid is now fulfilling the Eat Real Snack Food Canada Ltd. (ERSF) co-packing contract.
Work has been continuing since the start of the year to finalize preparation of the 3,000-square-foot packaging facility at the company’s Pitt Meadows headquarters. Installation of the machinery acquired from Eat Real Snack Foods, described in the agreement announced on Jan. 25, 2017, started during February and was finished earlier this month. The first order of dried fruit products to be packaged into stand-up zipper bags is under way and is near completion at the time of writing of this update.
Naturally Splendid chief executive officer Dave Eto stated: “Interest from other co-packing clients continues to grow and now we are introducing them to our facility. Sample runs of product and co-packing agreements are being discussed. This is also an opportunity to introduce our co-packing partners to other parts of our business, like HempOmega and food ingredients. Co-packaging facilities like ours are rare in Western Canada. We have tailored our co-packing services to be beneficial to companies ready to transition from hand-fill operations to a more automated process. These businesses may not currently have the volumes or capital to develop their own packaging operations and are looking to grow. By offering our services at this level, we provide processing capability to local processors ready for the next stage of their business.”
Naturally Splendid has also received $445,425 in cash and $120,000 in accounts payable settlement from the exercise of warrants previously granted. The warrants were exercised at prices of 30 cents, 35 cents and 40 cents for a total of 1,464,500 common shares being issued. Following the issuance of these shares, Naturally Splendid will have 76,010,649 common shares outstanding.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a multifaceted biotechnology company that is developing, producing, commercializing and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient-dense foods and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.
Click here to connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.